| Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study P Schmid, Y Nagai, R Agarwal, B Hancock, PM Savage, NJ Sebire, ... The Lancet 374 (9683), 48-55, 2009 | 313 | 2009 |
| EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis C Alifrangis, R Agarwal, D Short, RA Fisher, NJ Sebire, R Harvey, ... Journal of clinical oncology 31 (2), 280-286, 2013 | 247 | 2013 |
| Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment N Murugaesu, P Schmid, G Dancey, R Agarwal, L Holden, I McNeish, ... Journal of clinical oncology 24 (30), 4862-4866, 2006 | 190 | 2006 |
| Identification of 13 novel NLRP7 mutations in 20 families with recurrent hydatidiform mole; missense mutations cluster in the leucine-rich region CM Wang, PH Dixon, S Decordova, MD Hodges, NJ Sebire, S Ozalp, ... Journal of medical genetics 46 (8), 569-575, 2009 | 174 | 2009 |
| Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000–2009 A Sita-Lumsden, D Short, I Lindsay, NJ Sebire, D Adjogatse, MJ Seckl, ... British Journal of Cancer 107 (11), 1810-1814, 2012 | 171 | 2012 |
| Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE) J Wang, D Short, NJ Sebire, I Lindsay, ES Newlands, P Schmid, ... Annals of Oncology 19 (9), 1578-1583, 2008 | 162 | 2008 |
| The effects of trastuzumab on the CD4+ CD25+ FoxP3+ and CD4+ IL17A+ T-cell axis in patients with breast cancer C Horlock, B Stott, PJ Dyson, M Morishita, RC Coombes, P Savage, ... British journal of cancer 100 (7), 1061-1067, 2009 | 153 | 2009 |
| Granulosa cell tumours of the ovary: demographics, survival and the management of advanced disease P Savage, D Constenla, C Fisher, JH Shepherd, DPJ Barton, P Blake, ... Clinical Oncology 10 (4), 242-245, 1998 | 150 | 1998 |
| Why does cytotoxic chemotherapy cure only some cancers? P Savage, J Stebbing, M Bower, T Crook Nature Clinical Practice Oncology 6 (1), 43-52, 2009 | 141 | 2009 |
| The relationship of maternal age to molar pregnancy incidence, risks for chemotherapy and subsequent pregnancy outcome PM Savage, A Sita-Lumsden, S Dickson, R Iyer, J Everard, R Coleman, ... Journal of Obstetrics and Gynaecology 33 (4), 406-411, 2013 | 140 | 2013 |
| A phase I clinical trial of imiquimod, an oral interferon inducer, administered daily P Savage, V Horton, J Moore, M Owens, P Witt, ME Gore British journal of cancer 74 (9), 1482-1486, 1996 | 131 | 1996 |
| A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia T Powles, PM Savage, J Stebbing, D Short, A Young, M Bower, C Pappin, ... British journal of cancer 96 (5), 732-737, 2007 | 124 | 2007 |
| The management and outcome of women with post-hydatidiform mole ‘low-risk’gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l− 1 S McGrath, D Short, R Harvey, P Schmid, PM Savage, MJ Seckl British Journal of Cancer 102 (5), 810-814, 2010 | 109 | 2010 |
| Plasma kisspeptin is raised in patients with gestational trophoblastic neoplasia and falls during treatment WS Dhillo, P Savage, KG Murphy, OB Chaudhri, M Patterson, GM Nijher, ... American Journal of Physiology-Endocrinology and Metabolism 291 (5), E878-E884, 2006 | 103 | 2006 |
| Acute phase proteins, C-reactive protein and serum amyloid A protein, as prognostic markers in the elderly inpatient MB Hogarth, JR Gallimore, P Savage, AJ Palmer, JM Starr, CJ Bulpitt, ... Age and ageing 26 (2), 153-158, 1997 | 102 | 1997 |
| Risk of recurrent molar pregnancies following complete and partial hydatidiform moles N Eagles, NJ Sebire, D Short, PM Savage, MJ Seckl, RA Fisher Human reproduction 30 (9), 2055-2063, 2015 | 101 | 2015 |
| The demographics of molar pregnancies in England and Wales from 2000–2009 P Savage, J Williams, SL Wong, D Short, S Casalboni, K Catalano, ... J Reprod Med 55 (7-8), 341-5, 2010 | 101 | 2010 |
| Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia C Lybol, F Sweep, R Harvey, H Mitchell, D Short, CMG Thomas, ... Gynecologic oncology 125 (3), 576-579, 2012 | 99 | 2012 |
| A phase 1 study of AS1409, a novel antibody-cytokine fusion protein, in patients with malignant melanoma or renal cell carcinoma SM Rudman, MB Jameson, MJ McKeage, P Savage, DI Jodrell, M Harries, ... Clinical Cancer Research 17 (7), 1998-2005, 2011 | 97 | 2011 |
| The impact of molecular genetic diagnosis on the management of women with hCG-producing malignancies RA Fisher, PM Savage, C MacDermott, J Hook, NJ Sebire, I Lindsay, ... Gynecologic oncology 107 (3), 413-419, 2007 | 96 | 2007 |
